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Abstract
In this study we tested the hypothesis that type 2 diabetes impairs the dynamic response of leg vascular conductance (LVC)
during exercise. LVC (leg blood flow/mean arterial pressure) responses were studied during intermittent contractions
of the calf muscle in subjects with type 2 diabetes (n = 9), heavy controls (n = 10) and lean controls (n = 8) using a
biexponential function and an estimate of the mean response time (MRT). The time constant of the second phase of LVC
was significantly greater in type 2 diabetes (66.4 ± 29.2 s) than the heavy (22.2 ± 13.4 s) and lean (21.8 ± 9.3 s) controls,
resulting in a significantly greater MRT in the diabetic group (median [IQR] = 30.7 [24.6–46.5] s versus 16.3 [4.3–23.2]
s and 18.4 [13.7–19.3] s). These data support the hypothesis and suggest that a slowed hyperaemic response in the
exercising limb might contribute to exercise intolerance in diabetic subjects.
Keywords
Control, diabetes mellitus, exercise, hyperaemia, muscle

Introduction
Exercise intolerance is a major complication of type 2 diabetes1-4 that is associated with increased mortality.5 Although
the aetiology of exercise intolerance in type 2 diabetes is not
well understood, both a reduction in peak O2 uptake (V̇o2)1-4
and a profound slowing of the dynamic response of V̇o2 during submaximal exercise3, 6 have been observed in patients
with type 2 diabetes. These data are consistent with the
exaggerated fall in muscle PCr and pH during calf exercise
in type 2 diabetes,7 suggesting that mechanisms underlying
the control of V̇o2 are impaired in this disease.
The control of the dynamic response of V̇o2 during exercise is considered important to the process of fatigue and
tolerance of exercise.8 The control of V̇o2 depends, to some
extent, on the control of O2 delivery and muscle blood
flow.9,10 Recent evidence of a lower muscle blood flow
during steady-state, submaximal exercise2, 11 raises the possibility that the dynamic control of muscle blood flow is
impaired in type 2 diabetes. This would help explain both
the larger rise in the NIRS-derived deoxygenated haemoglobin in contracting muscle observed in type 2 diabetes6
and the faster decline in ‘microvascular PO2’ during twitch
contractions in the streptozotocin-induced diabetic rat.12
However, steady-state measures of limb blood flow shed
little light on the dynamic response prior to these measurements,13 and it is not known if the dynamic response

characteristics14 of muscle blood flow are altered in type 2
diabetes.
Systems control principles and assessment of dynamic
response characteristics have been used to explore the control of ventilation and V̇o2 during exercise for at least three
decades,14-16 but their application to the study of the control
of blood flow in human skeletal muscle is much more limited.13, 17 We have adapted venous occlusion plethysmography to the assessment of dynamic response characteristics
of leg blood flow in the contracting calf,18 an important
model of exercise in the study of peripheral vascular disease.19 Since this hyperaemic response is linked closely to
the control of vasodilation and, thus vascular conductance
in contracting skeletal muscle, we used this approach to test
the hypothesis that type 2 diabetes impairs the dynamic
response of leg vascular conductance during exercise.
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Methods
Subjects

Experimental overview

Nine women with type 2 diabetes, 10 overweight but otherwise healthy women (‘heavy controls’) and 8 lean and
healthy women (‘lean controls’) volunteered to participate
in this study. Healthy subjects were recruited from Trinity
College Dublin and diabetic subjects were recruited from
the Diabetes Unit at St Colmcilles Hospital, Dublin.
Exclusion criteria for participation in this study included
(1) a diagnosis of peripheral arterial disease (ankle:brachial
pressure index < 0.9), hypertension (systolic blood pressure
> 140 mmHg), coronary heart disease (described in the
following), neuropathy or retinopathy, (2) were smokers or
had smoked during the 12-month period preceding the
study or (3) were taking insulin, beta-blockers, calcium
channel blockers or any other antihypertensive drugs. All
diabetic subjects had a clinical history of diabetes that
ranged between 1 and 4 years; but immediately prior to the
study did not have clinical evidence of ischaemic heart disease (normal ECG during treadmill stress test) or renal and
hepatic dysfunction (urinary protein < 200 mg dl–1; urinary
creatinine levels < 2.2 mg dl–1).
Physical characteristics of the subjects are shown in
Table 1. Prior to and during this study the diabetic subjects
were taking either metformin (n = 5), avandmen (n = 1),
statins (n = 3) and/or an angiotensin-converting enzyme
(ACE) inhibitor (n = 1). None of the subjects were taking
contraceptive drugs during this period. Subjects were both
premenopausal (n = 11: 4 diabetic, 4 heavy and 3 lean) and
postmenopausal (n = 16: 5 diabetic, 6 overweight and
5 lean) whose ages ranged between 34 and 69 years. All
premenopausal subjects were tested during days 7–10 of
their menstrual cycle. Subjects were classified as sedentary
(≤1 hour week–1 of moderate intensity exercise in the preceding 3 months), which was confirmed using the Low
Level Physical Activity Recall (LOPAR) questionnaire.20,21
All subjects provided informed consent prior to their participation in this study, and the study was approved by the
institutional ethics committee and conducted in accordance
with the Declaration of Helsinki (2008).

Subjects were tested on 2 days. On the first day they were
familiarised with calf exercise and the protocol to be completed on the second day, and then they completed a series of
maximum efforts for the determination of maximum voluntary force (MVC). On the second day they performed three
bouts of high-intensity calf exercise during which leg blood
flow, mean arterial pressure and leg vascular conductance
were recorded. All tests were conducted at the same time of
the day (i.e. mid morning) and same ambient temperature
(i.e. 21°C). Subjects did not consume alcohol and caffeine
during a 24-hour period, or perform intense exercise for a
48 hour period, immediately before the testing sessions.

Calf exercise
Single-leg calf exercise was performed in an inclined position (67o) on a custom-built ergometer described previously
by us.18 For both the determination of MVC and the repeated
bouts of calf exercise, subjects were tilted rapidly from the
supine position and then initiated contractions within ~5 s
of reaching the inclined position. The calf MVC was determined as the highest force during a series of five maximal
contractions, each separated by 60 s of rest in the supine
position. Then, on a following day, the subject rested for
20 min in the supine position during which resting cardiovascular measurements were made (see the ‘Leg vascular
conductance’ section), before being tilted upright to the
inclined position and commencing calf exercise soon
after.18 Calf exercise consisted of intermittent and static
contractions of the calf muscle (6 s duty cycle: 2 s contraction, 4 s relaxation) at a target force of 70% MVC. Each
subject performed three calf exercise trials, separated by
20–30 min of rest in the supine position, and the duration of
each exercise trial was 6 minutes.

Leg vascular conductance
Estimates of leg vascular conductance (LVC) during rest
and calf exercise were based on simultaneous measurements

Table 1. Physical characteristics, fasting blood-borne measurements and calf strength (MVC) in the three groups of subjects. Median
and interquartile ranges are presented for weight and body mass index (BMI).

Type 2
Diabetes
Heavy
Controls
Lean Controls

Age (years)

Height (cm)

Weight (kg)

BMI (kg.m-2)

Glucose
(mmol/L)

Insulin
(mmol/L)

HBA1c (%)

MVC (N)

49.1 ± 5.7

165 ± 7

12.3 ± 4.8*

6.8 ± 1.0*†

764 ± 194

159 ± 4*

4.4 ± 0.9

11.3 ± 4.4*

5.7 ± 0.5

701 ± 194

53.1 ± 12.4

172 ± 7

32.5*
(27.9–38.8)
29.3
(29.0–31.0)*
22.6
(22.0–24.0)

8.1 ± 1.7*†

52.7 ± 14.7

85.5*
(74.5–117.9)
72.7
(69.1–86.1)
64.9
(63.0–71.0)

4.5 ± 0.4

7.6 ± 1.3

5.6 ± 0.2

766 ± 273

* Significantly different (p < 0.05) from the lean group.
† Significantly different (p < 0.05) from the heavy control group.
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of leg blood flow and mean arterial pressure (LVC = leg
blood flow/mean arterial pressure). Resting measurements
of leg blood flow and mean arterial pressure (MAP) were
made in the final three minutes of the initial 20 min rest
period and while the subject was in the supine position. In
contrast, exercise measurements of leg blood flow and MAP
were made in the inclined position (67o), a position that was
felt to better represent the haemodynamic conditions under
which these muscles work during daily activities (e.g. walking) than the supine position. Although it would have been
preferable to make both resting and exercise measurements
in the inclined position, it is difficult to obtain stable estimates of leg blood flow soon after tilting to the upright
position, as leg blood flow increases rapidly during tilting
and can take several minutes to stabilise when in the tilted
position.18 Moreover, our pilot studies18 showed that resting
on the ergometer in the inclined position for several minutes
often caused profound leg swelling and discomfort.
During calf exercise, leg blood flow, MAP and, thus, LVC
were measured during each period of relaxation between
contractions.18 For each of the three exercise trials this
yielded 60 measurements of these three variables. Leg blood
flow was measured during calf exercise using venous occlusion strain-gauge plethysmography,18 a technique which provides similar estimates of limb blood flow during exercise
when compared with Doppler ultrasound.22 Briefly, a thigh
cuff was inflated before exercise and maintained throughout
exercise at a pressure of 55 mmHg. Leg blood flow was then
assessed during the 4-s relaxation periods between contractions by measuring the change in leg volume (Figure 1)
using a mercury-in-Silastic strain gauge, placed around the

widest girth of the calf, and a plethysmograph (Hokanson
EC-6, Washington, USA). The plethysmographic estimates
of leg blood flow, normally expressed relative to the resting
limb volume (ml 100 ml–1 min–1), were converted to milli
litres per minute using an estimate of each subject’s leg
volume obtained from anthropometric measurements of the
leg.23 These blood flow estimates were then normalised to
the mean force (N) produced immediately before its measurement (ml–1 min–1 N–1). MAP was measured beat by beat
at rest and during exercise using applanation tonometry of
the radial artery (COLIN CBM7000, Japan). There were no
significant differences between these tonometric MAP values and those obtained on the contralateral arm every 2 minutes using an oscillometric method (Omron M7). LVC
during exercise was calculated by dividing leg blood flow by
the simultaneous measurement of MAP plus the estimated
hydrostatic pressure acting at the midpoint of the calf in this
inclined position.18, 24

Dynamic response characteristics of LVC
LVC responses (scaled to force) from the three exercise trials were averaged to yield a temporal profile of LVC based
on 60 averaged estimates for each subject (an example is
shown later in Figure 4). Of the 27 individual responses, 22
of them exhibited a clear biphasic pattern and the remaining five responses more closely resembled a monophasic
(two heavy control subjects) or triphasic pattern (one lean
control, one heavy control, one diabetic subject). On this
basis, the LVC responses of all subjects were fitted using a
biphasic function and the impact that deviations in measured responses from this biphasic response (in the case of
five subjects) has on interpretation of the data is dealt with
in the Discussion. The biphasic response was represented
by the biexponential function
LVC (t) = a + A1(1 – e–(t – TD1)/t1))U1 + A2(1 – e–(t – TD2)/t2))U2

Figure 1. A recording of force and the plethysmogram
(‘calf girth (V)’) during calf exercise that illustrates the pulsatile
increases in the calf girth (and volume) between contractions.
The voltage change between two contractions is shown
between the dashed vertical lines, and this voltage change is
converted to a volume change relative to the resting limb
volume (in ml 100 ml–1) using an electronic calibration internal
to the plethysmograph. Leg blood flow is then calculated from
this volume change and the period over which it occurs
(see Methods for further explanation).

where a represents LVC at t = 0, and the amplitude, time
delay and time constant of the first and second phases are
represented by A1–A2, TD1–TD2 and t1–t2, respectively.
The parameters U1 and U2 are conditional expressions that
limit the fitting of a particular phase to the period at and
beyond the time delay associated with that phase. Data that
exceeded the 95% prediction intervals during an initial fit
of a model were excluded, and no more than four data
points were removed from the original time series of
data. The models were fitted to the data using a weighted
least-squares nonlinear regression procedure (LevMarqdt,
TableCurve 2D, Jandel Scientific).
A graphic illustration of this biphasic model is shown in
Figure 2. The magnitude of the first phase of the LVC
response is defined by the parameter A1, and the temporal
response of this phase is defined with respect to its onset
relative to the start of exercise (i.e. the time delay TD1) and
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response was not as consistent between subjects as the LVC
response, a relatively simpler, monophasic function was
chosen.

Statistics

Figure 2. A graphic illustration of the biphasic model that was
fitted to leg vascular conductance responses.

its rate of increase towards its asymptotic value (t1). This
first phase is rapidly responding (small TD and t) and usually complete within ~10 s. The magnitude of the second
phase is defined by parameter A2, its onset is delayed relative to the onset of the first phase (i.e. TD2) at ~20–30 s
after exercise onset, and its rate of rise towards its asymptotic value (t2) is generally slower than that of the first
phase. The impact that the combined effect that both phases
has on the size and speed of the overall LVC response
for each subject can be represented by an ‘end-exercise’
response (i.e. LVC at t = 360 s) and a mean response time
(MRT) calculated using the fitted biphasic function. The
MRT, which represents the time to reach ~63% of the overall amplitude of the response from the baseline value, was
calculated as a weighted sum of the time delay and time
constant of each phase:
MRT = [A1/(A1 + A2).(TD1 + t1)] +
[A2/(A1 + A2).(TD2 + t2)]

Heart rate
Heart rate was measured from the R–R interval of singlelead (lead II) ECG at rest and every 5 s during each of the
three calf exercise trials and averaged to yield a single time
series of heart rate data for each subject. The dynamic
response of heart rate during calf exercise was fitted using
a monoexponential function:
Heart rate (t) = a + A(1 – e–(t – TD)/t)
where a is the baseline heart rate, A is the amplitude of the
exercise response, TD is the delay in rise of heart rate after
exercise onset and t is the time constant of the response.
The fitting procedures were identical to that described for
LVC, and because the dynamic structure of the heart rate

Cardiovascular data at rest and during exercise were compared between the three groups of subjects using a oneway analysis of variance (ANOVA) and differences were
located using Tukey’s post hoc test (SigmaStat 3.5, Systat,
USA). Data that were not normally distributed were analysed using a Kruskal–Wallis test and multiple comparisons were then performed using Dunn’s method. The level
of significance was set at p ≤ 0.05. Results are shown as
either mean ± SD for data that were normally distributed
or as median and interquartile ranges for data that were not
normally distributed.

Results
Calf exercise
There were no significant differences in MVC between the
three groups (Table 1). The submaximal force sustained
during calf exercise and averaged across all contractions
was not significantly different between subjects with type 2
diabetes (66% ± 4% MVC), heavy controls (70% ± 3%
MVC) and lean controls (67% ± 5% MVC).

Haemodynamic measurements
Plethysmographic measurements of resting blood flow
were not different between the diabetic (1.78 ± 0.40 ml 100
ml–1 min–1), heavy control (1.56 ± 0.57 ml 100 ml–1 min–1)
and lean control (1.69 ± 0.63 ml 100 ml–1 min–1) groups.
Leg blood flow was converted to units of ml min–1 using
anthropometric estimates of leg volume and then used to
measure leg blood flow and LVC at rest and during exercise, as reported in Table 2 and Figure 3. There were no
significant differences in leg blood flow, MAP or LVC
measurements at rest, at 20 s into exercise or at the end of
exercise between the three groups (Table 2). Although calf
exercise evoked a significant increase in MAP in all three
groups, this effect was small (~5–6 mmHg) and not different between the groups. The group-averaged responses of
leg blood flow, MAP and LVC during calf exercise are
shown in Figure 3. Representative LVC responses scaled to
force, as well as responses predicted from the fitting of the
biphasic function, are shown in Figure 4. Parameter estimates defining the biphasic response of LVC, as well as the
MRT and end-exercise values calculated using these parameter estimates, are shown in Table 3. The goodness of fit, as
reflected in the adjusted R2 value, was similar between the
type 2 diabetes (0.77 ± 0.11), heavy control (0.78 ± 0.18)
and lean control (0.76 ± 0.23) groups. The MRT was
significantly larger (p < 0.05) in type 2 diabetes than the
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Table 2. Leg blood flow, mean arterial pressure and leg vascular conductance measured at rest, at 20 s of exercise (Ex20) and the
end of 6 minutes of exercise (Exend) in type 2 diabetes, heavy controls and lean controls.

Type 2
Diabetes
Heavy
Controls
Lean
Controls

Leg Blood Flow (ml min–1)

Mean Arterial Pressure (mmHg)

Leg Vascular Conductance
(ml min–1 mmHg–1)

Rest

Ex20

Exend

Rest

Ex20

Exend

Rest

Ex20

Exend

49 ± 21

502 ± 322

742 ± 347

93.0 ± 7.0

94.3 ± 7.4

98.0 ± 8.7

0.53 ± 0.24

3.10 ± 1.90

4.5 ± 2.1

40 ± 14

610 ± 158

844 ± 313

91.4 ± 11.3

92.0 ± 11.9

96.8 ± 11.2

0.45 ± 0.20

4.01 ± 1.18

5.3 ± 2.0

39 ± 15

664 ± 331

909 ± 584

93.1 ± 10.8

93.6 ± 13.1

98.0 ± 14.4

0.43 ± 0.16

4.19 ± 2.16

5.6 ± 3.6

Table 3. Dynamic response characteristics of leg vascular conductance (LVC) during calf exercise in type 2 diabetes, heavy
controls and lean controls. Amplitudes (‘a’, ‘A1’, ‘A2’ and ‘end-exercise LVC’) are expressed in ml min–1 mmHg–1 N–1, and timebased parameters (‘TD1’, t1, TD2, t2 and MRT) are expressed in seconds. See Methods and Figure 2 for further description. Mean
response time (MRT) data were not normally distributed and are presented as median and interquartile range.
Baseline

Phase 1

a

A1

Phase 2
TD1

t1

A2

TD2

t2

Type 2
0.09 ± 0.04 0.54 ± 0.28 0.0 ± 0.0 3.4 ± 2.2 0.35 ± 0.20 27.1 ± 16.0 66.4 ± 29.2*
Diabetes
Heavy
0.09 ± 0.03 0.65 ± 0.22 1.3 ± 1.6 3.1 ± 3.3 0.36 ± 0.20 23.2 ± 7.1 22.2 ± 13.4
Controls
Lean Controls 0.07 ± 0.05 0.69 ± 0.26 0.5 ± 1.4 3.5 ± 2.3 0.37 ± 0.16 27.6 ± 15.1 21.8 ± 9.3

MRT

End-exercise
LVC

30.7
0.96 ± 0.35
(24.6-46.5)*
16.3
1.04 ± 0.35
(4.3-23.2)
18.4
1.10 ± 0.37
(13.7-19.3)

* Significantly different (p < 0.05) from the other groups.

control groups; whereas the end-exercise values were
similar between the three groups. The time constant of the
second phase (t2) was also significantly larger in type 2
diabetes than controls. None of the remaining parameters
were significantly different between the groups, although
the parameter TD1 tended to be different between the
groups (ANOVA, p = 0.06).

Heart rate
The baseline or resting heart rate (parameter a) immediately before calf exercise was not significantly different
between the type 2 diabetes (67 ± 11 bpm), heavy control
(67 ± 8 bpm) and lean control (61 ± 8 bpm) groups. When
comparing the dynamic response characteristics of heart
rate between these three groups (type 2 diabetes versus
heavy versus lean), there were no significant differences
in the amplitude (parameter A: 17.3 ± 4.4 versus 14.5 ±
4.7 versus 14.7 ± 8.4 bpm), time delay (parameter TD:
0.2 ± 0.6 versus 0.2 ± 0.3 versus 2.2 ± 3.5 s) or time
constant (parameter t: 6.7 ± 5.1 versus 11.8 ± 17.9 versus
14.2 ± 16 s).

Discussion
A major finding of the present study is that, compared with
both lean and heavy controls, the response of LVC and blood
flow during calf exercise was profoundly slowed in type 2
diabetes patients. In contrast, the response of MAP during
exercise was not different between these three groups. This
slowing of the hyperaemic response, evident in a signi
ficantly larger MRT for LVC, can be attributed entirely to
the slower rate of increase (i.e. larger time constant) of the
second phase of the hyperaemic response; whereas the first
phase was unaffected by type 2 diabetes. The similar LVC
and blood flow responses between lean and heavy controls
suggests that obesity per se is not responsible for the impaired
hyperaemic response in type 2 diabetes.

Dynamic response characteristics of leg vascular
conductance
In the presence of similar MAP responses between the three
groups, the slower leg blood flow response in type 2 diabetes can be attributed to a slower response of LVC (Figure 3)
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Figure 3. Group averaged responses of leg blood flow, mean
arterial pressure and leg vascular conductance during calf
exercise. ‘Mean arterial pressure’ in this figure is the local
arterial pressure estimated to act at the popliteal fossa, and so
the abrupt increase in this response after t = 0 s represents the
arterial pressure measured in the forearm plus the hydrostatic
pressure that acts at the knee when the subject is rapidly tilted
to the inclined position.

and, thus, vasodilation in the contracting skeletal muscle. A
high frequency of measurements of LVC during exercise
combined with empirical modelling of this dynamic
response enables the dynamic structure of these phases to
be resolved.14 The dynamic response of each phase is
assumed to be an exponential process defined by a set of

Figure 4. Leg vascular conductance (LVC) responses (open
circles) during calf exercise in an individual with type 2 diabetes,
a heavy control and a lean control. The continuous lines of best
fit illustrate the biphasic response of LVC. Note the relatively
slow response of the second hyperaemic phase in the diabetic
subject.

parameters that include the amplitude, time constant and
time delay. It has been suggested that each phase and the
parameters which define its structure potentially represent a
distinct set of underlying control mechanisms involved in
vascular control.13 In the present study, LVC was modelled
using a biexponential function on the basis that a biphasic
response was more apparent (22/27 subjects) than either a
monophasic or triphasic response. This is consistent with
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the biphasic response of arteriolar vasodilation to muscle
stimulation observed in the hamster cremaster muscle preparation,25,26 as well as the biphasic response of forearm
blood flow during moderate handgrip exercise.17 However,
as is apparent in forearm vascular conductance responses to
handgrip exercise,17 not all responses can be characterised
by the same number of phases. In the present study, two
subjects (both heavy controls) exhibited a monophasic
response and, thus, the estimated amplitude of the second
phase of these responses was zero, whereas three subjects
(one from each group) exhibited a triphasic response, and
this would result in an overestimate of the amplitude and
time constants of the second phase for these subjects.
However, neither of these observations can account for the
longer time constant of the second phase of the hyperaemic
response in the diabetic group compared with the lean or
heavy control groups.

Mechanisms of vascular control during exercise
A wide range of mechanisms probably contributes to the
biphasic control of vascular conductance in contracting
human muscles, although the precise contribution of any
one mechanism to either phase is not yet clear. The first
phase of vasodilation is initiated in response to the first contraction and is fully expressed within ~10–20 s.17 Likely
mechanisms involved in this initial phase include K+ release
into the interstitium27 and mechanical deformation of resistance vessels,28 as well as acetylcholine release from the
motor nerves,29 although there is some uncertainty regarding
its effectiveness in contracting human skeletal muscle.30,31 In
addition, the increase in the perfusion pressure under the
permissive influence of the ‘muscle pump’32 will increase
limb blood flow beyond that supported by vasodilation, and
it will do so in response to the first contraction and particularly when the limb is well below the level of the heart.18
The second phase of vasodilation is initiated at ~20–30 s
after exercise onset (Table 2),17 and it has been suggested
that the second phase is a flow-mediated, endotheliumdependent phase13 that is perhaps linked causally to the
decline in muscle PO2.25 It is likely that adenosine, a potent
vasodilator in human skeletal muscle,33 is linked to the
decline in muscle PO2 and contributes to this second
phase,25 despite the uncertainty about its time course of
accumulation in the interstitial fluid during the first phase
of the hyperaemic response.34 Both nitric oxide and prostaglandins may be involved in this vascular action of
adenosine or contribute independently to the exercise
hyperaemic response,35,36 although the inhibition of nitric
oxide synthesis has little effect on the rise in muscle blood
flow during exercise.31, 37 Both the classic autoregulation
(Bayliss mechanism) response and muscle sympathetic
nerve activation have the potential to modulate both biphasic responses; but their contributions to the dynamic

response characteristics have not, to the best of the authors’
knowledge, been established.

Mechanisms of impaired vascular control in diabetes
The slowed hyperaemic response observed in the present
study combined with the more rapid decline in muscle
microvascular PO2 and deoxygenated haemoglobin12, 38 in
type 2 diabetes suggests that the speed of the vasodilatory
response to a metabolic stimulus is impaired in this disease.
In contrast, neither the end-exercise value or phasic amplitudes of LVC were significantly affected by type 2 diabetes
(Table 2), suggesting that the capacity to vasodilate under
exercise conditions that evoke near-maximal blood flows18
remains intact. However, the phase 1 amplitude and endexercise value for LVC was 15–20% lower in the diabetic
group and, although this difference was not significant, the
large between-subject variation in responses might have
obscured an important physiological difference which
warrants further investigation. Nevertheless, given that the
initial hyperaemic response (phase 1) was not significantly
affected by type 2 diabetes, the slowed second phase
response is probably not due to a lower preceding flow
stimulus and above-mentioned mechanisms that underlie
it and is perhaps more likely explained by the failure of
endothelial-mediated vasodilation to amplify the early rise
in vascular conductance.
There are a number of potential mechanisms that underlie vascular dysfunction in type 2 diabetes.39 Of particular
relevance to the present findings is evidence that type 2
diabetes or hyperglycaemia impairs flow-mediated and
endothelial-dependent control of vascular resistance in the
human forearm.11, 40-41 Flow-mediated and endothelialdependent control mechanisms are thought to be central to
the time-dependent propagation of vasodilation from distal
to more proximal resistance vessels, a critical process in
controlling the hyperaemic response during muscle contractions.42 This process depends on the gap junction intercellular communication between endothelial cells and smooth
muscle,42 a process that is affected by high glucose concentrations.39 It is tempting to speculate that hyperglycaemiainduced disruption of this cell-to-cell mediated control over
the vascular response during exercise contributes to the
slowing of the second phase of the hyperaemic response in
type 2 diabetes.
To some extent the vascular mechanisms which impair the
muscle hyperaemic response in type 2 diabetes might depend
on the exercise model used and/or muscles studied. That the
amplitudes of the LVC response during high-intensity calf
exercise were unaffected by type 2 diabetes is consistent with
the maximal vasodilation in the hindlimb of the streptozotocin-induced diabetic rat being similar to control animals.43
However, they contrast with the lower steady-state values of
limb blood flow during lower intensity cycling11 and knee
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extension exercise.2 We can only speculate on the reasons for
this discrepancy and which might include both the intensity
of exercise (moderate versus ‘maximal’), the muscles studied (quadriceps versus calf) and the potential influence
of muscle atrophy (if present) on vascular conductance. In
addition, the influence of sympathetically mediated vasoconstriction in muscle on exercise hyperaemia in type 2 diabetes warrants further study, since it is increased at rest in an
insulin-resistant state44 and has been proposed as a possible
candidate for the age-related blunting of the hyperaemic
response to exercise involving the quadriceps muscles.45
The pharmacotherapy used by the present diabetic group,
which includes metformin, statins and ACE inhibitors, is
unlikely to account for the vascular dysfunction observed in
the present study given that these drugs generally enhance
vascular function.
It has been suggested that cardiac dysfunction, a major
complication of type 2 diabetes,7 might contribute to altered
blood flow or V̇o2 responses in type 2 diabetes.1-4 This, however, seems an unlikely mechanism in the present study
given the following: (1) LVC reflects vasodilation in the
contracting skeletal muscle; (2) differences in the leg blood
flow response is entirely a function of LVC given that the
pressor responses were similar between the three groups; (3)
the small but significant rise in MAP in the subjects with
type 2 diabetes demonstrates that cardiac function is sufficient to maintain blood pressure in the presence of a progressive decline in leg vascular resistance; and (4) there was no
difference in the dynamic response of heart rate during calf
exercise between the three groups. The common interpretation that a lowered cardiac output or slowed heart rate ‘kinetics’ observed during exercise in type 2 diabetes reflects
cardiac dysfunction1-4 is, in the absence of simultaneous arterial pressure measurements, tenuous. An alternative explanation for such cardiac responses is that they reflect vascular
dysfunction and altered responses of limb blood flow.

Relevance to VO2 and exercise tolerance
Like limb blood flow and vascular conductance, V̇o2 increases
in a biphasic manner during moderate exercise. Type 2 diabetes slows the second of these two phases of V̇o2,3, 6 and we
have observed the same effect on V̇o2 kinetics in a sample of
women that included many of those who participated in the
present study.46 Given the close temporal alignment between
the muscle blood flow and V̇o2 responses,47 the present findings suggest that this slowing is, at least in part, due to a
slowing of the second phase of hyperaemia. Impeding V̇o2
after the onset of exercise exaggerates the fall in muscle PCr
and pH, increase in Pi and loss of force production.48-51
Therefore, it is likely that the slowing of the hyperaemic
response (phase 2) contributes directly to the abnormal
metabolic responses in contracting muscle and the loss of
exercise tolerance in type 2 diabetes.1-4, 6, 46

Limitations
Although the resting ankle–brachial pressure index is a criterion measure of peripheral arterial disease, it can be inaccurate in diabetic subjects because of the presence of arterial
calcification and the associated stiffening. Angiography or
Doppler ultrasound was not performed in this study and so
we cannot rule out the presence of clinically significant
macrovascular disease and its potential influence on the
slowed hyperaemic response in the diabetic subjects. Both
pre- and post-menopausal women were studied and menopause appears to reduce endothelial-dependent vasodilation.52 However, this is unlikely to have introduced bias
in the results given that the distribution of pre- and postmenopausal women was similar in the three groups. The
accuracy of plethysmographic measurements of leg blood
flow has been questioned.53,54 However, recent work from
one of our laboratories shows very close agreement between
plethysmographic and Doppler ultrasound estimates of leg
blood flow during calf exercise.55

Conclusion
In conclusion, the present findings demonstrate a slowing of
the hyperaemic response during calf exercise in type 2 diabetes that is attributed to the second phase of this response.
This lays a foundation for further human research into the
mechanisms underlying this effect and their impact on metabolic control and exercise tolerance in type 2 diabetes.
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